Finding Your Biomarker: A Four-Step Framework For Building A Biomarker Strategy

Developing an effective bioanalytical strategy requires starting with the core clinical questions rather than selecting markers prematurely. Successful programmes evaluate indicators based on specific decision risks, mechanisms of action, and disease progression criteria. Choosing appropriate analytical platforms—such as immunoassays, liquid chromatography-tandem mass spectrometry, or flow cytometry—depends heavily on the target molecule type and required sensitivity. Furthermore, adopting a disease-agnostic mindset allows researchers to leverage relevant analytes across multiple therapeutic indications, optimizing data collection. Context-of-use parameters, including development phase, sample matrix, and patient population, ultimately dictate successful assay validation and execution.

To explore a streamlined framework containing over two hundred searchable markers and practical selection tools, read the full biomarker strategy guide.